A bstract Objectives The aims of this study were to evaluate changes in health-related quality of life (HRQoL) before ICU admission and after ICU discharge in elderly patients and to determine predictors of this HRQoL. Materials and methods This prospective study has been realized in the medical ICU (August 2012-March 2013). All patients 65 years of age or older who were hospitalized for ≥48 hours in our medical ICU have been included. The HRQoL was assessed 1 month prior to ICU admission in all the patients at admission and 3 months after ICU discharge for survivors using the Arabic version of MOS SF-36 questionnaire. Results We enrolled 118 patients (66 M: 55.9% and 52 F: 44.1%). The mean age was 72 ± 6 years. ICU mortality rate was 47.5% and three-month mortality rate was 55.1%. The reliability and validity of MOS SF-36 were satisfactory. Among the 53 survivors at follow-up, the subscales of MOS SF-36 decreased significantly at 3 months after ICU stay except the “Bodily Pain”. The physical component score (PCS) and mental component score (MCS) decreased also significantly. The independent factors strongly associated with PCS and its variations were: age ( β = −1.56, p = 0.001), prior functional status ( β = −22.10, p = 0.002) and SAPSII ( β = −0.16, p = 0.04). For MCS, these factors were: live alone ( β = 16.50, p = 0.006), previous functional status ( β = −9.09, p = 0.008) and existence of education level ( β = 2.98, p = 0.037). Conclusion We demonstrated a fall in the physical and psychical aspects of HRQoL 3 months after ICU discharge in the elderly patients. In addition to factors such as age, prior functional status and severity of illness, family status and educational level seem decisive in the post-ICU HRQoL. How to cite this article Zeggwagh Z, Abidi K, Kettani MNZ, Iraqi A, Dendane T, Zeggwagh AA. Health-related Quality of Life Evaluated by MOS SF-36 in the Elderly Patients 1 Month before ICU Admission and 3 Months after ICU Discharge. Indian J Crit Care Med 2020;24(7):531–538.
Figure 1: (a) Regular rounded nodule above the upper lip. (b) Pearly white dermoscopic appearance.
Aims: Alopecia areata is a non-scarring autoimmune disease, quite frequent in the pediatric population. Trichoscopy plays a fundamental role in its diagnosis, prognosis and therapeutic evaluation. Our objective was to describe the trichoscopic signs of alopecia areata in children while showing the most frequent signs in the pediatric population and their correlation with disease activity. Study Design: Retrospective descriptive study. Place and Duration of Study: Dermatology department of the CHU of Rabat Morocco over a two-year period. Methodology: We conducted a retrospective descriptive study collecting the cases of alopecia areata in children followed in the dermatology department of the CHU of Rabat Morocco over a two-year period. Results: A female predominance was noted (63.3%) with a sex ratio of 0.58. Concerning the antecedents, anxiety was at the top of the list with 56.7% of cases. 96.7% of the alopecia areata had been evolving for more than six months, mainly in the form of patchy alopecia 56.7%. In 60% of the children this alopecia areata was due to an emotional shock. Concerning trichoscopy the most common sign found in our study was black dots with a percentage of 80%, followed by: yellow dots 67.7%, exclamation point hair 60%, fluffy hair 53.3%, empty follicular openings 50%, tapered hair 40%, white hair 40%, angled hair 36.7%, biphasic hair 26.7%, pigtailed hair 16,7%. Sign of Pohl Pinkus has not been reported. Conclusion: Trichoscopy is a major tool in the diagnosis of alopecia areata in the pediatric population but also in the evaluation of the severity of the disease and its prognosis.
Cutaneous tuberculosis represents the fifth extrapulmonary form in Morocco after pleural, lymph node, urogenital, and intestinal tuberculosis. It is recognized to form a continuous immunopathologic spectrum, ranging from a high intensity to a low intensity of cell-mediated immunity, which explains the multiplicity and heterogeneity of anatomo-clinical forms. Association of multiple forms in the same patient is really rare. In this regard, we report a case of scrofuloderma on axillary tuberculosis adenitis associated to a lupus vulgaris in an immunocompetent patient, which was confirmed by histology, QuantiFERON-TB Gold test, and polymerase chain reaction. He received an antituberculous therapy with clinical regression of the lesions. In conclusion, cutaneous tuberculosis is still endemic in developing countries.The diagnosis is difficult because of its clinical polymorphism. That’s why it’s should be suspected clinically in the presence of any destructive or verrucous skin lesion evolving without healing for a long period and confirmed by bacteriological examinations and histology.
Orf is a rare viral zoonosis due to Parapoxvirus infection. Transmission to humans occurs through contact with infected goats and sheep. It may be complicated by fever, lymphangitis, lymphadenopathy, bacterial infection, and erythema multiforme. Only several cases of autoimmune bullous dermatoses have been described. Bullous pemphigoid secondary to an orf was found in ten patients. Herein, we report one case of a human orf complicated by bullous pemphigoid. This is an occasional complication following an orf. Knowledge of co-occurrence allows for the better management of the affected patient. This case is reported for its rare association. Key words: Bullous Pemphigoid; Orf; Orf-Induced Immunobullous Disease
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.